Testosterone
- Generic Name
- Testosterone
- Brand Names
- Androderm, Androgel, Axiron, Fortesta, Natesto, Striant, Testim, Testopel, Vogelxo
- Drug Type
- Small Molecule
- Chemical Formula
- C19H28O2
- CAS Number
- 58-22-0
- Unique Ingredient Identifier
- 3XMK78S47O
- Background
Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.
Testosterone was isolated from samples and also synthesized in 1935.
- Indication
Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.
- Associated Conditions
- Hypergonadotropic Hypogonadism, Hypogonadotrophic Hypogonadism, Idiopathic Hypogonadotropic Hypogonadism, Puberty, Delayed, Inoperable, metastatic Breast cancer
- Associated Therapies
- -
Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2014-04-14
- Lead Sponsor
- Gulhane School of Medicine
- Target Recruit Count
- 150
- Registration Number
- NCT02111434
- Locations
- ๐น๐ท
Gulhane School of Medicine, Ankara, Turkey
The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2014-04-11
- Lead Sponsor
- Gulhane School of Medicine
- Target Recruit Count
- 49
- Registration Number
- NCT02111473
- Locations
- ๐น๐ท
Gulhane School of Medicine, Ankara, Turkey
A Study of Axironยฎ in Healthy Participants
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2014-08-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 12
- Registration Number
- NCT02004132
- Locations
- ๐บ๐ธ
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach, Florida, United States
Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Aristotle University Of Thessaloniki
- Target Recruit Count
- 50
- Registration Number
- NCT01961336
- Locations
- ๐ฌ๐ท
Unit for Human Reproduction, 1st Dept of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
A Dose Ranging Study to Examine TDS-Testosterone 5%
- Conditions
- Interventions
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Transdermal Delivery Solutions Corp
- Target Recruit Count
- 48
- Registration Number
- NCT01894308
- Locations
- ๐ฌ๐ง
Advanced Therapies Centre, The London Clinic, London,, United Kingdom
Impact of Estradiol Addback
- Conditions
- Interventions
- First Posted Date
- 2013-05-27
- Last Posted Date
- 2019-06-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 43
- Registration Number
- NCT01862835
- Locations
- ๐บ๐ธ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment
- Conditions
- Interventions
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT01797718
- Locations
- ๐ซ๐ฎ
Kotka Central Hospital, Kotka, Finland
๐ซ๐ฎKuopio University Central Hospital, Kuopio, Finland
๐ซ๐ฎHelsinki University Central Hospital, Helsinki, Finland
Testosterone Antidepressant Augmentation in Women
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 101
- Registration Number
- NCT01783574
- Locations
- ๐บ๐ธ
Butler Hospital, Providence, Rhode Island, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
- Conditions
- Interventions
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2014-03-31
- Lead Sponsor
- Emotional Brain NY Inc.
- Target Recruit Count
- 207
- Registration Number
- NCT01743235
- Locations
- ๐บ๐ธ
Compass Research, Orlando, Florida, United States
๐บ๐ธMaryland Prime Care Physicians, Stevensville, Maryland, United States
๐บ๐ธCenter for Sexual Medicine at Sheppard Pratt, Townson, Maryland, United States
A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants
- First Posted Date
- 2012-11-12
- Last Posted Date
- 2014-10-16
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 30
- Registration Number
- NCT01725451
- Locations
- ๐บ๐ธ
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville, Indiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.